Pipeline

Our unique groundbreaking ProTcell platform has the potential for enabling a broad range of future applications including CAR ProTcell and TCR ProTcell for long-lasting, targeted immuno-oncology therapies.
Discover our different projects and ongoing clinical trials in our pipeline.